Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals RSUs — Total fair value of shares vested by Year
RSUs — Total fair value of shares vested ($M) ($M)
Vertex Pharmaceuticals RSUs — Total fair value of shares vested: $655M in FY2025, down 1.7% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Stock-based Compensation — RSU Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | RSUs — Total fair value of shares vested ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 655 | -1.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 666 | +53.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 433 | +16.3% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 373 | +32.5% | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Dec 31, 2021 | 281 | -28.2% | Form 10-K (filed 2024-02-15) ↗ |
| FY2020 | Dec 31, 2020 | 392 | +119.8% | Form 10-K (filed 2023-02-10) ↗ |
| FY2019 | Dec 31, 2019 | 178 | +70.0% | Form 10-K (filed 2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 105 | +215.7% | Form 10-K (filed 2021-02-11) ↗ |
| FY2017 | Dec 31, 2017 | 33.2 | +526.4% | Form 10-K (filed 2020-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 5.30 | -33.7% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 8 | – | Form 10-K (filed 2018-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals RSUs — Total fair value of shares vested ($M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rsu-vested-tot-fv
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.